Cholangiocarcinoma Foundation/X
Apr 27, 2025, 07:25
Cholangiocarcinoma Foundation Participates in Inaugural Meeting in Brazil Focused on Personalized Medicine
Cholangiocarcinoma Foundation shared a post on X:
“It is an honor for the Cholangiocarcinoma Foundation to participate in the inaugural Cholangiocarcinoma Foundation Meeting Brazil—a significant milestone in advancing personalized medicine for bile duct cancer.
This important gathering brings together international leaders in precision medicine, gastrointestinal cancer, and cholangiocarcinoma.
Together, we’re engaging in collaborative clinical case discussions and exploring innovations in genomic laboratories, cellular and gene therapy, and centers of excellence in robotic surgery, nuclear medicine, and interventional radiology.”
The Cholangiocarcinoma Foundation announced its participation in the inaugural Cholangiocarcinoma Foundation Meeting Brazil. The event convenes global experts in precision medicine and gastrointestinal oncology, featuring discussions on clinical cases and innovations in genomic labs, gene therapy, robotic surgery, nuclear medicine, and interventional radiology.
More posts featuring Cholangiocarcinoma Foundation.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 27, 2025, 07:18
Apr 27, 2025, 05:33
Apr 27, 2025, 05:14
Apr 27, 2025, 03:52